M Pharmaceutical Inc. announced that Mathew Lehman has resigned from the board of directors and from his position as president and CEO. The Company is undertaking a search for a new CEO. Mr. Lehman has advised the Company that he will be available to act as a consultant to the Company if so required.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
2018 | James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc | CI |
2018 | Callitas Health Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.53K | |
+24.97% | 46.71B | |
+48.83% | 41.8B | |
-1.19% | 41.52B | |
-3.42% | 29.55B | |
+10.45% | 25.78B | |
-21.17% | 19.26B | |
+1.22% | 12.14B | |
-3.18% | 12.08B | |
+27.34% | 11.98B |
- Stock Market
- Equities
- MPHMF Stock
- News Callitas Health Inc.
- M Pharmaceutical Inc. Announces Resignation of Mathew Lehman as President, CEO and from the Board of Directors